20/03/2026
When rigorous research meets real-world policy impact.
In our Medicaid expansion series, we consistently find the same pattern across cancers:
↓ Uninsured rates
↑ Medicaid coverage
→ Meaningful reductions in mortality
→ Improved survival outcomes
Our latest work focuses on renal medullary carcinoma, highlighting the population-level impact of Medicaid expansion. Presented at the Academic Surgical Congress 2026 (Florida).
Behind every study is rigorous causal inference methodology, multiple layers of review, and a commitment to continuous improvement. With over 100 peer reviews and 100+ peer-reviewed publications, I hold our work to the highest standard—each study better than the last.
Grateful for an incredible team that continues to push boundaries and produce research that doesn’t just get published—but informs policy and drives real-world health impact.
